Target intelligence / Profile preview

GA binding protein transcription factor subunit beta 1 (GABPB1)

Target
GABPB1
Molecular classification
Transcription factor
01

Overview

GA binding protein transcription factor subunit beta 1 (GABPB1) is the beta subunit of the GA binding protein complex, a member of the Ets family of transcription factors. GABPB1 forms a heterodimer or tetrameric complex with GABPA (alpha subunit), stimulating the transcription of target genes. It plays a crucial role in the regulation of nuclear-encoded mitochondrial genes, cell cycle progression, and the development and function of several cellular lineages including immune cells and neural stem/progenitor cells[1][2][3][4][5]. GABPB1 is expressed in multiple tissues, with essential functions in embryogenesis, neurogenesis, hematopoiesis, and immune system maturation[1][3][4]. Multiple transcript variants due to alternative splicing exist, leading to isoforms with potentially distinct biological activities[1][4]. Disruption of GABPB1 impairs stem and progenitor cell proliferation and has been associated with malignancies including retinoblastoma and roles in TERT promoter activation in cancer[3][5]. No direct pharmaceutical agents targeting GABPB1 are currently characterized in public databases.

Other names
GA-binding protein subunit beta-1GABPBGABPB2E4TF1BGABP subunit beta-1GABPB-1GABPB-2E4TF1-47E4TF1-53Nuclear respiratory factor 2Transcription factor E4TF1-47Transcription factor E4TF1-53NRF2B1NRF2B2
02

Biological functions

Transcriptional regulationCell cycle progressionCellular respiration/mitochondrial functionStem/progenitor cell proliferation and differentiationImmune response (e.g., T and B cell development)
03

Disease associations

Cancer (notably linked with retinoblastoma; implicated in tumorigenesis via TERT promoter activation)Neurodevelopmental disorders (related to neural stem/progenitor cell proliferation and differentiation)Other (essential for embryogenesis)
04

Safety considerations

Essential for early embryogenesis; complete loss results in embryonic lethalityFunctional redundancy among isoforms may complicate specific inhibition strategies

Beyond the preview

Go deeper on GA binding protein transcription factor subunit beta 1 (GABPB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GA binding protein transcription factor subunit beta 1 (GABPB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call